Remove Blog Remove Clinical Development Remove Protein Expression
article thumbnail

Present Treatments & Hopeful Future Directions for ALS Pharmacotherapies

Conversations in Drug Development Trends

Differences in regulatory sentiments and industry sponsors’ subsequent clinical development strategies historically restricted access based on geography. The opportunity to contribute to this progress has never been more critical for clinical researchers.

article thumbnail

Five Promising Treatment Areas in Early-Phase Drug Development in 2024

Alta Sciences

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues. Asia, and Europe.

article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What Questions Did They Answer? (Part 1)

FDA Law Blog: Drug Discovery

Where vector presence is detected, transgene mRNA and/or protein expression levels should also be measured. Section #3: Human Trials Finally, the guidance provides a quick overview of clinical study recommendations. For cell therapy products, the draft guidance notes that in vivo imaging techniques provide certain advantages.